JPS6255427B2 - - Google Patents

Info

Publication number
JPS6255427B2
JPS6255427B2 JP57050834A JP5083482A JPS6255427B2 JP S6255427 B2 JPS6255427 B2 JP S6255427B2 JP 57050834 A JP57050834 A JP 57050834A JP 5083482 A JP5083482 A JP 5083482A JP S6255427 B2 JPS6255427 B2 JP S6255427B2
Authority
JP
Japan
Prior art keywords
weight
styrene
butadiene
unit content
tube
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP57050834A
Other languages
Japanese (ja)
Other versions
JPS58165864A (en
Inventor
Toshiaki Nakamaru
Kunihiro Ishikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP57050834A priority Critical patent/JPS58165864A/en
Publication of JPS58165864A publication Critical patent/JPS58165864A/en
Publication of JPS6255427B2 publication Critical patent/JPS6255427B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Description

【発明の詳細な説明】 発明の背景 技術分野 この発明は医療用器具に係り、特には、移行性
物質を含まない重合体材料で形成された医療用器
具に関する。 先行技術および問題点 医療用器具特にカテーテル等医療用液体を搬送
するためのチユーブは、柔軟性、透明性、経済性
等の点から、現在、軟質ポリ塩化ビニル
(PVC)で形成されたものが多い。しかしなが
ら、軟質PVCは可塑剤(例えば、ジオクチルフ
タレート(DOP)等)等の移行性物質を多量に
含んでいる。この可塑剤は、例えば軟質PVC製
のチユーブを薬液や血液等の医療用液体と長時間
に渡つて接触させると該液体中に溶出・移行し、
その結果チユーブの物性特に柔軟性が低下する恐
れがある。また、液体中に移行した可塑剤の人体
に対する影響も取沙汰されている。 そこで、DOPの溶出の問題点を解決するため
に、DOPを含む軟質PVCをプラズマ処理した
り、DOPに代る移行性の少ない可塑剤が検討さ
れているが充分に満足できるものではなく、その
安全性についても疑問視されている。また、
DOPのような低分子可塑剤の代りに高分子可塑
剤を使用した軟質PVCもあるが、これは低分子
可塑剤に比べ可塑化効率が悪い上、DOP同様そ
の安全性について疑問視されている。 一方、軟質PVCに代る素材例えばポリエチレ
ン、ポリウレタン等も検討されているが医療用器
具として用いるには、ポリエチレンは物性特に柔
軟性、透明性の点で従来品の軟質PVCに比べ汎
用性に乏しく、又、ポリウレタンは経済性の点で
やはり汎用性に乏しい。 発明の目的 したがつて、この発明の目的は移行性物質を含
有する可塑剤を用いず、しかも柔軟性、透明性に
優れた医療用器具を提供することにある。 この発明によれば、少なくとも体液または血液
と接触すべき部分であつて柔軟性の要求される部
分がブタジエン単位含有率5ないし40重量%のス
チレン―ブタジエンラジアルブロツク共重合体
〔A〕5ないし50重量%、およびスチレン系熱可
塑性エラストマー95ないし50重量%よりなる重合
体材料で形成された医療用器具が提供される。 前記スチレン系熱可塑性エラストマーは、通常
ブタジエン単位含有率40ないし90重量%のスチレ
ン―ブタジエン―スチレンテレブロツク共重合
体、ブタジエン単位含有率40ないし90重量%のス
チレン―ブタジエンシングルブロツク共重合体、
ブタジエン単位含有率40ないし90重量%のスチレ
ン―ブタジエンラジアルブロツク共重合体
〔B〕、オレフイン単位含有率40ないし90重量%の
スチレン―オレフイン―スチレンテレブロツク共
重合体、またはこれらいずれか2種以上の混合物
である。 また、この発明の医療用器具は医療用液体搬送
チユーブの形態にあることが好ましい。 発明の具体的説明 本発明者らは、軟質PVCに代るべき医療用器
具材質について種々検討した結果、ある種のスチ
レン―ブタジエンラジアルブロツク共重合体とス
チレン系熱可塑性エラストマーとを所定の割合で
ブレンドすることによつて透明性があり、優れた
柔軟性と適度な弾性を備え、成形性が良好であ
り、人工胃液〔I〕(局方)、人工腸液(局方)等
への移行性物質を実質上含まない医療用器具に適
した重合体材料を得ることができることを見い出
しこの発明を完成するに至つた。 この発明の医療用器具には、医療用液体搬送チ
ユーブ例えばカテーテル、輸液用チユーブ、輸血
用チユーブ、体外循環血液回路チユーブ等、並び
に血液分離用バツグが含まれる。特に好ましいも
のは既述の医療用液体搬送チユーブ特にカテーテ
ルである。以下、医療用器具として吸引カテーテ
ルを例にとつてこの発明を図面を参照しつつ詳し
く説明する。 添付図面に示した吸引カテーテルは例えば内径
1.7〜4.5mmおよび外径2.7〜6.7mmを有し、以後詳
述する重合体材料で形成されたチユーブ11を備
えている。チユーブ11の一端には硬質プラスチ
ツク製のアダプター12が設けられている。ま
た、チユーブ11の開放他端はチユーブ壁に対し
てある角度をなし、その近傍のチユーブ壁には吸
引口13が形成されている。 チユーブ11はブタジエン単位含有率が5ない
し40重量%好ましくは10ないし25重量%のスチレ
ン―ブタジエンラジアルブロツク共重合体〔A〕
5ないし50重量%好ましくは10ないし40重量%お
よびスチレン系熱可塑性エラストマー95ないし50
重量%好ましくは90ないし60重量%よりなる重合
体材料で形成されている。この重合体材料におい
てスチレン―ブタジエンラジアルブロツク共重合
体は柔軟性で弾性のあるスチレン系熱可塑性エラ
ストマーに対して適度の硬さと良好な成形性を付
与する役割をなし、そのブタジエン単位含有率が
5重量%未満の場合は硬さが増加しすぎるととも
に透明性を損ねる。一方そのブタジエン単位含有
率が40重量%を越えると、軟らかくなりすぎて適
度な硬さを付与できないため、使用中に容易に折
れ曲がつてチユーブの閉塞が起きたりまた表面の
平滑性が失われたりする。分子量は通常およそ5
万ないし20万である。 上記重合体材料の他方の成分であるスチレン系
熱可塑性エラストマーはスチレンブロツクをハー
ドセグメントとし、ブタジエン、またはオレフイ
ンブロツクをソフトセグメントとするエラストマ
ーである。その例を挙げると、ブタジエン単位含
有率が40ないし90重量%のスチレン―ブタジエン
―スチレンテレブロツク共重合体、ブタジエン単
位含有率40ないし90重量%スチレン―ブタジエン
シングルブロツク共重合体、オレフイン単位含有
率40ないし90重量%のスチレン―オレフイン―ス
チレンテレブロツク共重合体またはこれら2種以
上の混合物である。これらスチレン系熱可塑性エ
ラストマーは市販されている。 以上の成分および配合比でなる重合体材料は成
分同志の相容性が良好であるので透明であり、低
分子可塑剤や安定剤を含まず、柔軟性に優れ、ま
た成形性も良好である。さらに、この重合体材料
が示す柔軟性は温度変化に対しての変化が少な
く、軟質PVCのように低温でかたくなるという
ことがない。 なお、以上述べた重合体材料によつてこの発明
の医療用器具を作製するためには通常の押出し成
形、射出成形等特に押出し成形を用いることがで
きる。 以下、この発明の実施例を記す。 実施例 1 表1に示す6種の配合比よりなる重合体材料か
ら押出し成形によつて添付図面に示すようなカテ
ーテル用チユーブを作製した。これらカテーテル
用チユーブについて、各種物性および安全性を調
べた結果を表2に示す。
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to medical devices, and more particularly, to medical devices formed from migratory-free polymeric materials. Prior Art and Problems Medical devices, especially tubes for transporting medical liquids such as catheters, are currently made of flexible polyvinyl chloride (PVC) due to their flexibility, transparency, and economy. many. However, soft PVC contains large amounts of migratory substances such as plasticizers (eg, dioctyl phthalate (DOP), etc.). For example, when a tube made of soft PVC is brought into contact with a medical liquid such as drug solution or blood for a long period of time, this plasticizer will be eluted and transferred into the liquid.
As a result, the physical properties of the tube, particularly its flexibility, may deteriorate. In addition, the effects of plasticizers transferred into liquids on the human body have been discussed. Therefore, in order to solve the problem of DOP elution, plasma treatment of soft PVC containing DOP and plasticizers with low migration properties are being considered to replace DOP, but these are not fully satisfactory. There are also questions about its safety. Also,
There is also soft PVC that uses a polymer plasticizer instead of a low-molecular plasticizer like DOP, but this has lower plasticizing efficiency than low-molecular plasticizers, and like DOP, its safety is questionable. . On the other hand, alternative materials to soft PVC, such as polyethylene and polyurethane, are being considered, but polyethylene is less versatile than conventional soft PVC in terms of physical properties, especially flexibility and transparency, for use in medical devices. Also, polyurethane is not very versatile in terms of economy. Purpose of the Invention Therefore, the purpose of the present invention is to provide a medical device that does not use a plasticizer containing a migratory substance and has excellent flexibility and transparency. According to this invention, at least the portion that is in contact with body fluids or blood and that requires flexibility is a styrene-butadiene radial block copolymer [A] with a butadiene unit content of 5 to 40% by weight. % by weight, and from 95 to 50% by weight of a styrenic thermoplastic elastomer. The styrenic thermoplastic elastomer is usually a styrene-butadiene-styrene teleblock copolymer with a butadiene unit content of 40 to 90% by weight, a styrene-butadiene single block copolymer with a butadiene unit content of 40 to 90% by weight,
A styrene-butadiene radial block copolymer [B] with a butadiene unit content of 40 to 90% by weight, a styrene-olefin-styrene terrestrial block copolymer with an olefin unit content of 40 to 90% by weight, or two or more of these. It is a mixture of Preferably, the medical device of the invention is in the form of a medical liquid delivery tube. DETAILED DESCRIPTION OF THE INVENTION As a result of various studies on materials for medical devices that could replace flexible PVC, the present inventors discovered that a certain type of styrene-butadiene radial block copolymer and a styrene thermoplastic elastomer were used in a predetermined ratio. By blending, it has transparency, excellent flexibility and appropriate elasticity, good moldability, and transferability to artificial gastric fluid [I] (pharmacopoeia), artificial intestinal fluid (pharmacopoeia), etc. The inventors have discovered that it is possible to obtain a polymer material suitable for medical devices that does not substantially contain substances, and have completed the present invention. The medical devices of the present invention include medical liquid transport tubes such as catheters, infusion tubes, blood transfusion tubes, extracorporeal circulation blood circuit tubes, etc., and blood separation bags. Particularly preferred are the medical liquid delivery tubes mentioned above, especially catheters. Hereinafter, the present invention will be described in detail using a suction catheter as an example of a medical device with reference to the drawings. The suction catheter shown in the accompanying drawings has an internal diameter of e.g.
It comprises a tube 11 having a diameter of 1.7 to 4.5 mm and an outer diameter of 2.7 to 6.7 mm and made of a polymeric material as will be described in detail hereinafter. A hard plastic adapter 12 is provided at one end of the tube 11. Further, the other open end of the tube 11 forms a certain angle with respect to the tube wall, and a suction port 13 is formed in the tube wall in the vicinity thereof. Tube 11 is a styrene-butadiene radial block copolymer [A] having a butadiene unit content of 5 to 40% by weight, preferably 10 to 25% by weight.
5 to 50% by weight, preferably 10 to 40% by weight and 95 to 50% by weight of styrenic thermoplastic elastomer
% by weight, preferably from 90 to 60% by weight of a polymeric material. In this polymer material, the styrene-butadiene radial block copolymer plays a role in imparting appropriate hardness and good moldability to the flexible and elastic styrene thermoplastic elastomer, and its butadiene unit content is 5. If it is less than % by weight, hardness increases too much and transparency is impaired. On the other hand, if the butadiene unit content exceeds 40% by weight, it will become too soft and cannot be given appropriate hardness, so it will easily bend during use, causing blockage of the tube or loss of surface smoothness. or The molecular weight is usually around 5
It is between 10,000 and 200,000. The other component of the above polymer material, the styrene thermoplastic elastomer, is an elastomer having styrene blocks as hard segments and butadiene or olefin blocks as soft segments. Examples include styrene-butadiene-styrene teleblock copolymers with a butadiene unit content of 40 to 90% by weight, styrene-butadiene single block copolymers with a butadiene unit content of 40 to 90% by weight, and olefin unit content. It is a 40 to 90% by weight styrene-olefin-styrene block copolymer or a mixture of two or more of these. These styrenic thermoplastic elastomers are commercially available. Polymer materials made of the above components and blending ratios have good compatibility among the components, so they are transparent, do not contain low-molecular plasticizers or stabilizers, have excellent flexibility, and have good moldability. . Furthermore, the flexibility of this polymer material is less sensitive to temperature changes, and it does not stiffen at low temperatures like soft PVC. In order to produce the medical device of the present invention using the polymer material described above, conventional extrusion molding, injection molding, etc., particularly extrusion molding, can be used. Examples of this invention will be described below. Example 1 Catheter tubes as shown in the attached drawings were produced by extrusion molding from polymer materials having the six compounding ratios shown in Table 1. Table 2 shows the results of examining various physical properties and safety of these catheter tubes.

【表】【table】

【表】 第1表に示す割合で、ドライブレンドした後、
直接押出成形機(φ20mmスクリユー、L/D=
20、圧縮比=2.25)に仕込み、内径3.1mm、外径
4.7mmの管状チユーブ成形品を押出成型した。こ
のように作製したカテーテル用チユーブの含有材
質の移行性を各々人工胃液(日局、JPX)、人工
腸液(日局、JP)について、37℃±0.25、28日
間本発明カテーテル用チユーブを浸漬したのちの
重量変化率(%)を〔{(28日後の重量)―(浸漬
前の重量)}/浸漬前の重量〕×100で表わした。
28日間浸漬後の重量が減少した場合、負の記号を
付け、増加した場合正の記号を付けた。ここで比
較例としてDOPを可塑剤として34重量%含む軟
質PVCを材料としたカテーテル用チユーブも取
り上げた。
[Table] After dry blending in the proportions shown in Table 1,
Direct extrusion molding machine (φ20mm screw, L/D=
20, compression ratio = 2.25), inner diameter 3.1mm, outer diameter
A 4.7 mm tubular tube molded product was extruded. The migration properties of the materials contained in the catheter tube thus prepared were evaluated by immersing the catheter tube of the present invention in artificial gastric fluid (Japanese Pharmacopoeia, JPX) and artificial intestinal fluid (Japanese Pharmacopoeia, JP) at 37°C ± 0.25 for 28 days. The weight change rate (%) afterward was expressed as [{(weight after 28 days) - (weight before immersion)}/weight before immersion]×100.
A negative sign was given if the weight decreased after 28 days of immersion, and a positive sign was given if it increased. As a comparative example, a catheter tube made of soft PVC containing 34% by weight of DOP as a plasticizer was also taken up.

【表】【table】

【表】 この結果表2に示すように軟質PVCに比べ本
発明品の場合重量減少率が著しく低くまたスチレ
ン―ブタジエンラジアルブロツク共重合体〔A〕
を50重量%より多くした場合のD、5重量%未満
としたE、Fに比べてもその重量減少率が低いこ
とが確認された。 また厚生省基準(塩化ビニル樹脂製血液セツト
基準)による安全性の試験でも本発明品は基準に
合格しており、チユーブ表面の平滑性で評価した
成形性の結果および目視による透明性の結果及び
100%伸長時の引張応力で評価した柔軟性の結果
もすべて良好であつた。 実施例 2 表3に示す2種の配合比よりなる重合体材料か
ら実施例1に示したのと同様の方法により添付図
面に示すようなカテーテル用チユーブを作製し
た。これらカテーテル用チユーブについて各種物
性および安全性を調べた結果を表4に示す。
[Table] As shown in Table 2, the weight loss rate of the product of the present invention is significantly lower than that of soft PVC, and the styrene-butadiene radial block copolymer [A]
It was confirmed that the weight loss rate was lower than that of D, which had more than 50% by weight, and E and F, which had less than 5% by weight. In addition, the product of the present invention passed the safety test according to the Ministry of Health and Welfare standards (standard for vinyl chloride resin blood sets), and the moldability results evaluated by tube surface smoothness and the visual transparency results.
All the results of flexibility evaluated by tensile stress at 100% elongation were also good. Example 2 A tube for a catheter as shown in the attached drawings was prepared by the same method as shown in Example 1 from polymer materials having the two types of compounding ratios shown in Table 3. Table 4 shows the results of examining various physical properties and safety of these catheter tubes.

【表】【table】

【表】【table】

【表】 発明の具体的効果 この発明の医療用器具は、少なくとも体液また
は薬液と接触し、柔軟性の要求される部分が既述
の重合体材料により形成されているので、優れた
柔軟性があり、低温においても柔軟性の低下が少
ないとともに、移行性物質を含まないので、血液
や薬液と長時間接触しても含有物質の溶出・移行
に基く物性の変化がなく、安全性の面からも優れ
ている。また、特にカテーテル等のようにチユー
ブ先端部の操作をチユーブ後端部の操作でおこな
うような医療用器具の場合、その操作性が非常に
優れている。
[Table] Specific Effects of the Invention The medical device of the present invention has excellent flexibility because at least the portion that comes into contact with body fluids or medical fluids and requires flexibility is formed of the above-mentioned polymer material. It has minimal loss of flexibility even at low temperatures, and since it does not contain migratory substances, there is no change in physical properties due to elution or migration of the contained substances even if it comes into contact with blood or drug solutions for a long time, so it is safe. is also excellent. In addition, especially in the case of medical instruments such as catheters in which the distal end of the tube is operated by operating the rear end of the tube, the operability is very excellent.

【図面の簡単な説明】[Brief explanation of the drawing]

添付の図面はこの発明の一態様に従う吸引カテ
ーテルの正面図。 11……チユーブ、12……アダプター、13
……吸引口。
The accompanying drawing is a front view of a suction catheter according to one embodiment of the present invention. 11...tube, 12...adapter, 13
...Suction port.

Claims (1)

【特許請求の範囲】 1 少なくとも体液または薬液と接触すべき部分
であつて柔軟性および透明性の要求される部分が
ブタジエン単位含有率5ないし40重量%のスチレ
ン―ブタジエンラジアルブロツク共重合体5ない
し50重量%、およびスチレン系熱可塑性エラスト
マー95ないし50重量%よりなる重合体材料で形成
されたことを特徴とする、医療用液体搬送チユー
ブの形態にある医療用器具。 2 スチレン系熱可塑性エラストマーが、ブタジ
エン単位含有率40ないし90重量%のスチレン―ブ
タジエン―スチレンテレブロツク共重合体、ブタ
ジエン単位含有率40ないし90重量%のスチレン―
ブタジエンシングルブロツク共重合体、ブタジエ
ン単位含有率40ないし90重量%のスチレン―ブタ
ジエンラジアルブロツク共重合体、オレフイン単
位含有率40ないし90重量%のスチレン―オレフイ
ン―スチレンテレブロツク共重合体、またはこれ
らいずれか2種以上の混合物である特許請求の範
囲第1項記載の医療用器具。
[Scope of Claims] 1. At least the portion that comes into contact with body fluids or medical fluids and that requires flexibility and transparency is a styrene-butadiene radial block copolymer 5 or 5 with a butadiene unit content of 5 to 40% by weight. A medical device in the form of a medical liquid conveying tube, characterized in that it is made of a polymeric material consisting of 50% by weight and 95 to 50% by weight of a styrenic thermoplastic elastomer. 2 The styrenic thermoplastic elastomer is a styrene-butadiene-styrene teleblock copolymer with a butadiene unit content of 40 to 90% by weight, a styrene with a butadiene unit content of 40 to 90% by weight.
Butadiene single block copolymer, styrene-butadiene radial block copolymer with a butadiene unit content of 40 to 90% by weight, styrene-olefin-styrene teleblock copolymer with an olefin unit content of 40 to 90% by weight, or any of these. The medical device according to claim 1, which is a mixture of two or more of the above.
JP57050834A 1982-03-29 1982-03-29 Medical instrument Granted JPS58165864A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57050834A JPS58165864A (en) 1982-03-29 1982-03-29 Medical instrument

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57050834A JPS58165864A (en) 1982-03-29 1982-03-29 Medical instrument

Publications (2)

Publication Number Publication Date
JPS58165864A JPS58165864A (en) 1983-09-30
JPS6255427B2 true JPS6255427B2 (en) 1987-11-19

Family

ID=12869777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57050834A Granted JPS58165864A (en) 1982-03-29 1982-03-29 Medical instrument

Country Status (1)

Country Link
JP (1) JPS58165864A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5227448A (en) * 1975-08-26 1977-03-01 Abbott Lab Thermoelastic polymers containing medical sealing and resealing material block radial polymers
JPS5227447A (en) * 1975-08-26 1977-03-01 Abbott Lab Thermoplastic polymer mextures containing medical sealing and resealing material radial block polymers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5227448A (en) * 1975-08-26 1977-03-01 Abbott Lab Thermoelastic polymers containing medical sealing and resealing material block radial polymers
JPS5227447A (en) * 1975-08-26 1977-03-01 Abbott Lab Thermoplastic polymer mextures containing medical sealing and resealing material radial block polymers

Also Published As

Publication number Publication date
JPS58165864A (en) 1983-09-30

Similar Documents

Publication Publication Date Title
US4198983A (en) Catheter made of a thermoplastic material having improved softness and low friction
US4196731A (en) Silicone-containing thermoplastic polymers for medical uses
KR100255283B1 (en) Coextruded medical grade port tubing
US4154244A (en) Balloon-type catheter
US4327726A (en) Connector member for dissimilar materials
GB1587522A (en) Polyurethane film bag for the storage and deep-freezing of blood and blood constituents
JPS5841862B2 (en) medical equipment
JPS62139668A (en) Laminated plug for syringe
IE893648L (en) Plastic composition with anti-hemolytic effect
US5928216A (en) Surgical/medical tubing and containers for use in conveying medical solutions and the like
JPS60259264A (en) Medical device
AU2008240022A1 (en) NON-PVC system tube for biomedical
US5733268A (en) Medical tubing and containers for use in conveying medical solutions and the like
JPS6255427B2 (en)
JP2006061226A (en) Catheter having connector
JP4419448B2 (en) Medical tube
JPH08150216A (en) Tube connector
JPH048061B2 (en)
JPH03505600A (en) plasticized polymer composition
US5324760A (en) Polymer alloy of polybutadiene and olefinic thermoplastics
JP2894793B2 (en) Platelet storage bag
JP4806890B2 (en) Medical molded parts
JPH08131537A (en) Base material for medical use, and medical device using same
JP2001252348A (en) Tube for medical treatment
JPS6158192B2 (en)